Skip to content
MMJ Gazette
  Tuesday 13 January 2026
  • About
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Authors
  • Home
  • News
  • CBD
  • Cannabis
  • Drugs
  • Marijuana
  • Tobacco
  • Law
Trending
January 13, 2026Texas Medical Cannabis Set to Explode in 2026 January 10, 2026Cannabis Firms Face HR Compliance Crunch in 2026 January 9, 2026Oregon Cannabis Sales Drop in 2025 Despite Record Harvests January 8, 2026Kentucky’s Medical Weed Market Faces Major Supply Hurdles January 7, 2026Vireo Growth Buys Eaze in $47M Cannabis Shakeup January 5, 2026Chanda Macias Drives Global Medical Cannabis Access January 3, 2026Trump’s Marijuana Shift: Answers to Your Burning Questions on Tax Relief January 2, 2026Marijuana Rescheduling Sparks Tax Relief Hopes – But When? January 1, 2026Three Trends Reshaping U.S. Cannabis in 2026 December 30, 2025Trump’s Cannabis Shift Sparks Hope for Parkinson’s Relief
MMJ Gazette
MMJ Gazette
  • About
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Authors
MMJ Gazette
  Cannabis  OCS: Decline in High-THC Flower Following Launch of Testing Program
CannabisNews

OCS: Decline in High-THC Flower Following Launch of Testing Program

Lars BeckersLars Beckers—April 11, 20240
FacebookTwitterPinterestLinkedInTumblrRedditVKWhatsAppEmail

The Ontario Cannabis Store (OCS) has reported a decline in the number of high-THC cannabis flower products available in its catalog. This decrease comes after the launch of a temporary THC testing program earlier this year. Let’s delve into the details:

OCS

The Testing Program

On January 4, 2024, the OCS initiated a temporary THC testing program. Under this program, the provincial cannabis wholesaler selects high-THC cultivars entering its warehouse for secondary testing. The goal is twofold: to verify specific label claims and to address broader concerns about highly inflated THC levels on cannabis product labels.

How It Works

  1. Secondary Testing: High-THC products undergo secondary testing to ensure their THC levels align with what is stated on their labels. Any inconsistencies may lead to further scrutiny, including potential re-labeling or return-to-vendor.
  2. Re-Labeling: Since the program’s inception, several products carried out by the OCS have been re-labeled with lower THC ranges. This adjustment reflects a commitment to accurate labeling and consumer safety.
  3. Acceptable Variance: Products within an acceptable range of variance (±15% from the label claim) are released for sale. For example, a product labeled at 20% THC could fall within approximately 17–23% THC due to this variance.
  4. Disputes and Further Testing: Producers whose products fall outside the acceptable range have five days to dispute the results. If disputed, the OCS sends the product back to the same third-party lab for additional testing. If it fails again, the producer bears the cost of the return.

Industry Concerns

The issue of high-THC products, particularly cannabis flowers, remains contentious. While research typically shows THC percentages in most cannabis flowers to be in the high teens to low twenties, some products on the market advertise well over 30 percent THC—a statistically improbable but not impossible claim. Industry stakeholders, including labs, producers, consumers, and retailers, have called for accurate THC labeling. The OCS’s testing program aims to address these concerns and foster a vibrant cannabis marketplace.

In summary, the OCS’s temporary THC testing program seeks to gather information, evaluate industry reports, and promote testing and sampling standards. By doing so, it contributes to a more transparent and reliable cannabis market.

FacebookTwitterPinterestLinkedInTumblrRedditVKWhatsAppEmail

Lars Beckers

Lars Beckers is a distinguished senior content writer at MMJ Gazette, bringing a wealth of experience and expertise to the realm of medical marijuana and cannabis-related content. With a deep understanding of the industry and a passion for sharing knowledge, Lars's articles offer readers comprehensive insights and engaging narratives in the dynamic world of cannabis. Known for his meticulous research, clarity of expression, and commitment to delivering high-quality content, Lars brings a seasoned perspective to his work, educating and informing audiences on the latest trends and developments in the field.

Federal Agents Seize Legal Cannabis Products in New Mexico
Study Reveals: Majority of Utah Medical Cannabis Patients Turn to Unregulated Sources
Related posts
  • Related posts
  • More from author
Cannabis

Texas Medical Cannabis Set to Explode in 2026

January 13, 20260
Cannabis

Cannabis Firms Face HR Compliance Crunch in 2026

January 10, 20260
Cannabis

Oregon Cannabis Sales Drop in 2025 Despite Record Harvests

January 9, 20260
Load more
Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

SEARCH
PROMOTIONS
RECENT POSTS
  • Texas Medical Cannabis Set to Explode in 2026
  • Cannabis Firms Face HR Compliance Crunch in 2026
  • Oregon Cannabis Sales Drop in 2025 Despite Record Harvests
  • Kentucky’s Medical Weed Market Faces Major Supply Hurdles
  • Vireo Growth Buys Eaze in $47M Cannabis Shakeup
  • Chanda Macias Drives Global Medical Cannabis Access
  • Trump’s Marijuana Shift: Answers to Your Burning Questions on Tax Relief
  • Marijuana Rescheduling Sparks Tax Relief Hopes – But When?
  • Three Trends Reshaping U.S. Cannabis in 2026
  • Trump’s Cannabis Shift Sparks Hope for Parkinson’s Relief
    © MMJ Gazette. 2024
    • About
    • Contact Us
    • Privacy Policy
    • Terms and Conditions
    • Authors